BioCentury
ARTICLE | Clinical News

Benzhydrocodone regulatory update

November 11, 2013 8:00 AM UTC

KemPharm said it completed an end-of-Phase II meeting with FDA and now plans to submit an NDA to FDA in 3Q14 for KP201 to treat acute moderate to moderately severe pain. KemPharm will submit the appli...